Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Jazz

With the rising prevalence of chronic diseases, increasing cell and gene therapies, and rising tech adoption in the biotech industry, the oncology market is booming. Amid this backdrop, investors could consider quality biotech stocks Pyxis Oncology (PYXS), Immatics (IMTX), and Jazz Pharmaceuticals (JAZZ), having significant upside potential. Continue reading.

StockNews.com

Lauri Markkanen Officially Signs Huge Contract Extension With Utah Jazz, per Report

Lauri Markkanen will be a member of the Utah Jazz for a while yet— and he'll be very well-compensated. On Wednesday, ESPN's Adrian Wojnarowski reported Markkan

Sports Illustrated

Details Emerge on Stalled Trade Talks Between Warriors, Jazz for Lauri Markkanen

The Jazz coveted young Warriors players that Golden State was unwilling to give up in a deal.

Sports Illustrated

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Lauri Markkanen Can't Be Traded in 2024-25 With New Contract Per NBA Trade Rules

It's a matter of timing.

Sports Illustrated

Jazz to Sign Star Forward Lauri Markkanen to Massive Contract Extension, per Report

After being floated as a trade piece throughout the offseason, Markkanen is set to secure a contract extension to lock him in with the Jazz.

Sports Illustrated

ESPN’s Zach Lowe floats Rockets as potential Lauri Markkanen trade suitor with Jazz

“The Rockets have been mentioned, just because they have a million young players,” ESPN’s Zach Lowe says of the Lauri Markkanen trade market.

USA Today Sports Media Group

Russell Westbrook Has Funniest Stat About Being Traded Twice to Utah Jazz

This is Westbrook's second time being traded to the Utah Jazz since last February.

Sports Illustrated

Read news from The Economist, FT, and more,
with one subscription

Russell Westbrook One Step Closer to Nuggets After Clippers-Jazz Trade, per Report

The former NBA MVP is expected to eventually join Nikola Jokic in Denver.

Sports Illustrated

Jazz asking price for Lauri Markkanen could scare off Warriors

The Utah Jazz have set a lofty asking price for a potential Lauri Markkanen trade.

USA Today Sports Media Group

Warriors, Jazz Continue Discussing Lauri Markkanen Trade

Golden State is targeting Lauri Markkanen in trade talks.

Sports Illustrated

Breakers heading back to US for NBA pre-season games

The New Zealand Breakers will represent the NBL in two exhibition games against NBA opposition in October, taking on the Utah Jazz and Oklahoma City Thunder.

AAP

Simone Fontecchio Agrees To Two-Year, Million Deal With Pistons

Simone Fontecchio signs a million deal with the Detroit Pistons after showcasing his scoring prowess. His sharpshooting from beyond the arc makes him a...

Top News

Lauri Markkanen is reportedly Golden State’s top trade target

The Utah Jazz star could be the Golden State Warriors top trade target during the offseason.

USA Today Sports Media Group

2024 NBA draft order for Round 2 on Day 2: All 58 picks

Here's a look at the 2024 NBA Draft order for Round 2.

USA Today Sports Media Group

Get all your
news in one place.

100’s of premium titles.
One news app.

USA Today Sports Media Group

2024 NBA Mock Draft: The final projections on the day before the draft

Investors Business Daily

Jazz Dives — But Key Rival Praxis Surges — On Essential Tremor Drug Failure

Jazz stock toppled Thursday — but shares of key rival Praxis surged — after its essential tremor drug failed in midstage testing.

Motor1

The Owner of This Shelby Cobra Used It to Learn How to Drive Stick

Jazz icon Herbie Hancock bought this Cobra with his first real paycheck. He still owns it today.

StockNews.com

The biotech industry is poised for significant growth due to the rising orphan drug formulations and the surging popularity of plant-based products. Hence, quality biotech stocks, Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Jazz Pharmaceuticals (JAZZ) could be ideal investments for solid returns. Read more….

Get all your
news in one place.

100’s of premium titles.
One news app.

USA Today Sports Media Group

Could the Utah Jazz be a trade partner for veteran Chicago Bulls guard Zach LaVine?

We've seen some interest from the Los Angeles Lakers and Philadelphia 76ers, but what about the Jazz?

Sports Illustrated

Biggest Blowout in NBA Finals History: A Full Breakdown

An otherwise competitive rivalry turned historically lopsided for one game.

USA Today Sports Media Group

NBA fans loved how the Jazz got rid of their terrible black and yellow uniforms after just 2 seasons

The Jazz's new purple and white jerseys should have never gone away.

StockNews.com

4 Biotech Stocks Ready to Surge in June

The biotech industry's prospects look promising due to the use of advanced technologies like AI and VR for research, the growing popularity of tailored treatments and biotech devices, a rise in chronic diseases, and increased R&D spending. Therefore, investors could consider buying biotech stocks Innoviva (INVA), Halozyme Therapeutics (HALO), Jazz…

USA Today Sports Media Group

Bronny James’ pre-draft workout with the Suns fuels speculation he could be a first-round pick

Would the Suns actually target Bronny James in the first round?

USA Today Sports Media Group

Could Bulls’ Patrick Williams sign an offer sheet with the Jazz?

Could Chicago Bulls forward Patrick Williams sign an offer sheet with the Utah Jazz in free agency?

StockNews.com

3 Biotech Stocks Poised for May Surges

The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.